Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 5 Other solid neoplasm 2 Thoracic 1 Sarcoma 1 Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 1145 Cisplatin 874 Pemetrexed 832 pembrolizumab 604 Paclitaxel 597 Docetaxel 535 Gemcitabine 424 Radiotherapy 374 Erlotinib Hydrochloride 367 Nivolumab 322 Bevacizumab 322 Etoposide 294 durvalumab 254 Drug Therapy 233 osimertinib 217 atezolizumab 207 Radiosurgery 188 Gefitinib 177 Vinorelbine 145 130-nm albumin-bound paclitaxel 123 Magnetic Resonance Spectroscopy 120 Ipilimumab 118 Cetuximab 113 anlotinib 104 tislelizumab 103 Topotecan 101 Cyclophosphamide 101 Taxes 99 Irinotecan 95 Albumin-Bound Paclitaxel 92

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × AC 7700 × Thoracic × Clear all

NCT01263886 2015-12-21

DISRUPT

Sanofi

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡